Terns Pharmaceuticals Inc. (NASDAQ: TERN) 30-day option implied volatility is at 32; compared to its 52-week range of 17 to 48. Call put ratio 1 call to 1.2 puts into Merck (MRK) to acquire for $53 per share in cash, or $6.7B.